Back to Journals » International Journal of Nanomedicine » Volume 7

Medicine at nanoscale: a new horizon

Authors Khan AU

Received 23 April 2012

Accepted for publication 25 April 2012

Published 18 June 2012 Volume 2012:7 Pages 2997—2998

DOI https://doi.org/10.2147/IJN.S33238

Asad U Khan

Medical Microbiology and Molecular Biology Laboratory, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India

Concerning the recent article published in your journal on antibiofilm surface functionalization of catheters.1 This is an admirable approach to inhibit biofilm formation on the surfaces of various implants. Currently, a number of biomedical devices and implants are commonly used in hospitals and clinics. Over the past few decades, a number of knee and hip implants have been introduced to save lives and restore quality of life. Moreover, a significant increase in the use of stents, heart valves, vascular grafts, catheters, and other implantable devices are being introduced worldwide. However, regrettably, these surfaces are prone to microbial infections and hence device-related infections have become a major source of infection which may ultimately lead to a high mortality rate in the hospital setting.2

View original paper by Lellouche and colleagues.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery

Yuan H, Bao X, Du YZ, You J, Hu FQ

International Journal of Nanomedicine 2012, 7:5119-5128

Published Date: 26 September 2012

Effects of pH-sensitive chain length on release of doxorubicin from mPEG-b-PH-b-PLLA nanoparticles

Liu R, He B, Li D, Lai Y, Chang J, Tang JZ, Gu Z

International Journal of Nanomedicine 2012, 7:4433-4446

Published Date: 14 August 2012

Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages

Murata M, Narahara S, Umezaki K, Toita R, Tabata S, Piao JS, Abe K, Kang JH, Ohuchida K, Cui L, Hashizume M

International Journal of Nanomedicine 2012, 7:4353-4362

Published Date: 9 August 2012

Controlled release of 5-fluorouracil and progesterone from magnetic nanoaggregates

Ragab DM, Rohani S, Consta S

International Journal of Nanomedicine 2012, 7:3167-3189

Published Date: 29 June 2012

Comparing the effects of nano-sized sugarcane fiber with cellulose and psyllium on hepatic cellular signaling in mice

Wang ZQ, Yu Y, Zhang XH, Floyd ZE, Boudreau A, Lian K, Cefalu WT

International Journal of Nanomedicine 2012, 7:2999-3012

Published Date: 18 June 2012

Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups

Hong SC, Lee JH, Lee J, Kim HY, Park JY, Cho J, Lee J, Han DW

International Journal of Nanomedicine 2011, 6:3219-3231

Published Date: 7 December 2011

Electrostatic self-assembly of multilayer copolymeric membranes on the surface of porous tantalum implants for sustained release of doxorubicin

Guo X, Chen M, Feng W, Liang J, Zhao H, Tian L, Chao H, Zou X

International Journal of Nanomedicine 2011, 6:3057-3064

Published Date: 28 November 2011

In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection

Torben Gjetting, Nicolai Skovbjerg Arildsen, Camilla Laulund, et al

International Journal of Nanomedicine 2010, 5:371-383

Published Date: 25 May 2010